GE Aerospace CFO Rahul Ghai said he is confident a durability issue with the GE9X mid-seal will not hold up Boeing's 777X entry into service next year. The comments ease a vendor risk weighing on the program and GE's engine backlog. If sustained, this could lift near-term sentiment and potential orders for GE's aerospace business.
Industry peers back GE's planned $12B castings deal, potentially strengthening GE Aerospace's supply chain. Honeywell’s praise hints at a broader move toward insourcing in aerospace. Risks include regulatory clearance and integration costs, but success could boost GE margins by capturing captive casting capacity.
GE Aerospace will buy CPP for $11.75 billion to lock essential turbine blade casting capacity amid persistent bottlenecks and ~30% demand growth by 2030. Musk's SpaceX in-house blade plan has pressured incumbents like Howmet, increasing competitive scrutiny. GE will continue external sourcing, but the deal signals a capacity-expansion strategy with potential long-term margin benefits.
GE Aerospace announced a $12 billion acquisition of Consolidated Precision Products to address shortages of precision jet engine parts and gain access to critical casting technology. The move strengthens vertical integration within GE's aerospace supply chain, potentially improving production resilience and long-term margin stability, though integration risks and financing considerations could weigh on near-term metrics.
GE Aerospace announced it will acquire CPP, a castings maker, from Warburg Pincus and Berkshire Partners for $11.75 billion to strengthen its supply-chain resilience for aerospace components. The deal signals a strategic push to reduce sourcing risk and secure critical parts, potentially improving production throughput but raising near-term cash outlay and integration considerations.
Nelson Peltz's Trian Fund Management boosted its GE HealthCare stake in Q2 while maintaining its GE Aerospace position. The move signals activist oversight across GE's successor firms and could pressure governance and capital-allocation decisions to unlock value in healthcare and aerospace amid macro headwinds.